However tough some of the recent seasons have been, Wolves are still a top-flight club. For much of the 30 years before Fosun ...

Co., Ltd. ("Fosun Pharma"or "the Group"; Stock Code: 600196.SH, 02196.HK), a leading global pharmaceutical and healthcare company driven by innovation, announced its annual results for the year ended ...

SHANGHAI, March 25, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"or "the Group"; Stock Code: 600196.SH ...

Being in a position of relative safety means the club can now plan early for next season, but will they make the most of it?

Kedaara Capital and TA Associates are in talks to acquire a significant minority stake in Sagent Pharma, valued at $500-600 ...

U.S. law firm Pillsbury Winthrop Shaw Pittman has added capital markets partner Samuel Ng to its Hong Kong office from the ...

Chinese pharmaceutical company Fosun Pharmaceutical Group (SHA: 600196) has agreed to sell its stake in private hospital ...

Brian asked: Why are Fosun holding on to the club and risking relegation every season? Would they consider appointing an experienced director of football to allow Jeff Shi to run the business side?

SHANGHAI -- Chinese drugmaker Fosun Pharmaceutical Group has agreed to sell its stake in a hospital group to U.S. private equity firm Warburg Pincus for $124.08 million.